• English
    X

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    Maryland Department of Health
    HealthChoice

    ​​​​​​

    HealthChoice Monitoring and Evaluation Activities

    ​Effective January 1, 2022, the Centers for Medicare & Medicaid Services (CMS) approved and renewed Maryland's §1115 demonstration waiver, known as HealthChoice, for a five-year period. This page will serve as a centralized location for documents and activities related to HealthChoice monitoring and evaluation.

    Background​​

    ​​​Per the terms of the H​ealthChoice Demonstration Renewal as directed by 42 CFR 431.420(c), Maryland must conduct a post-award forum within six (6) months of implementing the demonstratio​n and annually thereafter. The forum is intended to provide the public with the opportunity to offer meaningful comment on the progress of the demonstration.

    Per the Standard Terms and Conditions set by CMS, the state shall post the final approved Evaluation Design, Interim Evaluation Report, and Summative Evaluation Report on the state Medicaid website within thirty (30) days of approval by CMS. Links to these d​ocuments and accompanying supporting documentation are available below on this page.

    Please direct any questions to mdh.healthchoicerenewal@maryland.gov.

    Summative Evaluation

    Post-Award Forums​​​ and Annual Evaluation Reports​

    2023 Post-Award Forum

    The 2023 Post-Award Forum will be held on Thursday, May 25th, 2023, during the Maryland Medicaid Advisory Committee meeting, from 1:00 - 3:00 PM via GoToWebinar. Interested attendees may register for the meeting at the following link: https://attendee.gotowebinar.com/register/8194586921687632912. 


    The Post-Award Forum will include time for public comment, and written comments may be submitted to mdh.healthchoicerenewal@maryland.gov. If you are interested in signing up to provide public comment during the meeting, please email Hannah Markus and Meredith Lawler at hannah.markus@maryland.gov and meredith.lawler@maryland.gov by close of business on Tuesday, May 23rd, 2023.    ​

    2022 Post-Award Forum

    The 2022 Post-Award Forum took place on Thursday, May 26, 2022, during the Maryland Medicaid Advisory Committee meeting. Due to COVID-19, the meeting was held via webinar. 

    ​Meeting Reference Documents

    2021 Post-Award Forum

    The 2021 Post-Award Forum took place on Thursday, May 27, 2021. Due to COVID-19, the meeting was held via webinar and in conjunction with the second HealthChoice Waiver Renewal Public Hearing.
     

    Meeting Reference Documents​

    2020 Post-Award Forum

    The 2020 Post-Award Forum took place on Thursday, May 28, 2020. Due to COVID-19, the meeting was held via webinar. 
     

    Meeting Reference Documents

     

    2019 Post-Award Forum

    The 2019 Post-Award Forum took place on Thursday, May 23, 2019 at 3:00 in room L1 at the Maryland Department of Health (MDH) in Baltimore, Maryland. The Post-Award Forum was held in conjunction with the HealthChoice Waiver Amendment Baltimore Public Hearing.
     

    Meeting Reference Documents

     

    2018 Post-Award Forum

    The 2018 Post-Award Forum took place on Thursday, May 24, 2018 at 3:00 in room L1 at MDH in Baltimore, Maryland. The Post-Award Forum was held in conjunction with the HealthChoice Waiver Amendment Baltimore Public Hearing.
      

    Meeting Reference Documents

     

    2017 Post-Award Forum

    The 2017 Post-Award Forum was held within six months of implementation, as required, on June 22, 2017 at MDH in Baltimore, Maryland.
     

    Meeting Reference Documents

     ​Annual Evaluation Reports from Prior Years


    ​​